A5052035076- Smoking Behavior and Cessation
- Obesity, Physical Activity, Diet
- Behavioral Health and Interventions
- Nicotinic Acetylcholine Receptors Study
- Consumer Attitudes and Food Labeling
- Eating Disorders and Behaviors
- Asthma and respiratory diseases
- Respiratory and Cough-Related Research
- Nutritional Studies and Diet
- Substance Abuse Treatment and Outcomes
- Pediatric health and respiratory diseases
- Homelessness and Social Issues
- Health Systems, Economic Evaluations, Quality of Life
- Air Quality and Health Impacts
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- School Health and Nursing Education
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Health disparities and outcomes
- Diet and metabolism studies
- Obesity and Health Practices
- Gastroesophageal reflux and treatments
- Media Influence and Health
- Innovations in Medical Education
- Cannabis and Cannabinoid Research
- Olfactory and Sensory Function Studies
Queen Mary University of London
2016-2025
AstraZeneca (Sweden)
2021
Wolfson Foundation
2021
UK Centre for Tobacco & Alcohol Studies
2010-2016
Leipzig University
2009-2014
University of London
1988-2013
University of Dental Medicine
2011
Transnational Press London
2011
Pfizer (United States)
2011
Primary Health Care
2006
E-cigarettes are commonly used in attempts to stop smoking, but evidence is limited regarding their effectiveness as compared with that of nicotine products approved smoking-cessation treatments.
Smoking cessation treatment is now integrated into many health-care systems and a major research effort under way to improve current success rates. Until results from randomized clinical trials have been reported in different ways, leading problems of interpretation. We propose six standard criteria comprising the 'Russell Standard' (RS). These are applicable aids where participants defined target quit date there face-to-face contact with researchers or clinic staff, as follows. (1)...
As the popularity of electronic cigarettes (e-cigarettes) increases, it is becoming important to find out more about characteristics e-cigarette users, why and how they use product whether e-cigarettes are used exclusively or in combination with conventional cigarettes. The objective this study was investigate patterns effects user beliefs safety benefits.E-cigarette users Poland were recruited online asked participate a web-based survey. participants provided information on their smoking...
Electronic cigarettes (EC) may have a potential for public health benefit as safer alternative to smoking, but questions been raised about whether EC should be licensed medicine, with accurate labelling of nicotine content. This study determined the content cartridges most popular brands in United Kingdom and levels they deliver vapour, estimated safety consistency delivery across batches same product proxy quality control individual within industry.We studied five UK (six products) high...
SYNOPSIS In 227 smokers' clinic clients who managed at least one week of abstinence, ratings withdrawal symptoms were used to predict subsequent return smoking. Depression, time spent with urges smoke, and difficulty not smoking during the first abstinence significantly associated lapse back second week. Depression predicted status third No a fourth The predictive power was over above that smoke intake dependence. findings provide some support for view reduction may be worthwhile target in...
Since nicotine gum was introduced in the 1980s, replacement therapy has become most widely used pharmacological smoking cessation treatment. Some smokers prefer acute oral forms, but many reject chewing gum. We tested safety and efficacy of a new polacrilex lozenge for cessation.Double-blind, placebo-controlled, randomized clinical trial with parallel arms testing 2- 4-mg lozenges. Smokers (n = 1818) were assigned to dose on basis dependence, assessed by time first cigarette day....
<h3>Background</h3> There are several nicotine replacement products on the market, and physicians likely to be asked with increasing frequency about which of these their patients should use. <h3>Objective</h3> To provide a basis for rational advice by comparing polacrilex (gum), transdermal patch, nasal spray, an inhaler. <h3>Design</h3> Randomized trial assessments at quit date 1, 4, 12 weeks later. <h3>Setting</h3> Hospital smokers' clinic. <h3>Patients</h3> Male female community...